Friday, April 16, 2021

Experimental antiviral for COVID-19 effective in hamster study

The experimental antiviral drug MK-4482 significantly decreased levels of virus and disease damage in the lungs of hamsters treated for SARS-CoV-2 infection, according to a new study. MK-4482, delivered orally, is now in human clinical trials.

from Top Health News -- ScienceDaily https://ift.tt/3wXH0Hj

No comments:

Post a Comment

Scientists create “smart” DNA drug that targets cancer cells with extreme precision

Scientists have created a programmable drug system that can zero in on cancer cells with unprecedented accuracy. Built from synthetic DNA, i...